Sanne Y. Smith-Apeldoorn, MD, is affiliated with the University of Groningen, University Medical Center Groningen, Department of Psychiatry in the Netherlands. The author has published research on the use of ketamine in the treatment of depression, including its safety when combined with monoamine oxidase inhibitors in treatment-resistant depression and its application in patients with a history of psychosis or current psychotic symptoms. Collaborations include work with Jeanine Kamphuis, Jolien K. E. Veraart, Robert A. Schoevers, Annemarie van der Meij, and Jan Spijker.
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
